Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. The cyclopropyl and fluorine substituents enhance cell permeability and target specificity. Shows activity in modulating signaling pathways involved in tumor growth and cell proliferation. Investigated for its potential in treating solid tumors and hematologic malignancies due to its ability to selectively inhibit specific tyrosine kinases. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and metabolic stability.